Molina Healthcare grants Romney trust 304 shares
The grant is one quarterly portion of a $220,000 annual director equity award, calculated using the common stock’s closing price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Molina Healthcare, Inc. reported a grant of 304 common shares to Ronna Romney Revocable Trust in connection with director Ronna Romney’s services. The grant was based on the October 1, 2026 closing price of $180.85 per share under the company’s 2025 Equity Incentive Plan. The trust held 18,173 shares following the grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2, F3, F4 | 304 | $180.85 | $55K |
Footnotes (4)
- F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
- F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
- F3. Represents the closing price of the Issuer's common stock on October 1, 2026.
- F4. All shares held by Ronna Romney Revocable Trust.
Key Figures
Key Terms
2025 Equity Incentive Plan financial
annual equity award financial
closing price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How is MOH’s director equity award structured?
AI-generated analysis. How Rhea-AI works. Not financial advice.